Chakraborty, P., & Chakraborty, K. (2022). Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment. European Journal of Biological Research, 12(1), 1-10. Retrieved from http://www.journals.tmkarpinski.com/index.php/ejbr/article/view/519